JP Morgan Chase’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $161K | Buy |
8,199
+1,094
| +15% | +$20.2K | ﹤0.01% | 5584 |
|
|
2025
Q4 | $97.6K | Sell |
7,105
-955
| -12% | -$14.9K | ﹤0.01% | 5905 |
|
|
2025
Q3 | $143K | Sell |
8,060
-532
| -6% | -$8.42K | ﹤0.01% | 5718 |
|
|
2025
Q2 | $130K | Sell |
8,592
-964
| -10% | -$16K | ﹤0.01% | 5481 |
|
|
2025
Q1 | $154K | Buy |
9,556
+1,247
| +15% | +$23.2K | ﹤0.01% | 5362 |
|
|
2024
Q4 | $145K | Buy |
8,309
+359
| +5% | +$6.33K | ﹤0.01% | 5607 |
|
|
2024
Q3 | $139K | Sell |
7,950
-230
| -3% | -$3.92K | ﹤0.01% | 5570 |
|
|
2024
Q2 | $91.5K | Sell |
8,180
-1,053
| -11% | -$9.92K | ﹤0.01% | 5559 |
|
|
2024
Q1 | $80.4K | Sell |
9,233
-2,375
| -20% | -$21.8K | ﹤0.01% | 5765 |
|
|
2023
Q4 | $142K | Buy |
11,608
+1,127
| +11% | +$7.8K | ﹤0.01% | 5570 |
|
|
2023
Q3 | $42.2K | Sell |
10,481
-2,402
| -19% | -$14.9K | ﹤0.01% | 5855 |
|
|
2023
Q2 | $92.6K | Buy |
12,883
+12,871
| +107,258% | +$82.2K | ﹤0.01% | 5499 |
|
|
2023
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 7116 |
|
|
2022
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 6893 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 6764 |
|
|
2022
Q2 | $0 | Sell |
12
-6,525
| -100% | -$16.4K | ﹤0.01% | 6780 |
|
|
2022
Q1 | $32K | Buy |
6,537
+1,181
| +22% | +$9.67K | ﹤0.01% | 5943 |
|
|
2021
Q4 | $79K | Hold |
5,356
| – | – | ﹤0.01% | 5775 |
|
|
2021
Q3 | $116K | Sell |
5,356
-2,803
| -34% | -$60.3K | ﹤0.01% | 5498 |
|
|
2021
Q2 | $134K | Sell |
8,159
-21,166
| -72% | -$403K | ﹤0.01% | 5438 |
|
|
2021
Q1 | $695K | Sell |
29,325
-2,511
| -8% | -$75.1K | ﹤0.01% | 4473 |
|
|
2020
Q4 | $760K | Buy |
31,836
+26,729
| +523% | +$425K | ﹤0.01% | 4122 |
|
|
2020
Q3 | $62K | Sell |
5,107
-5,026
| -50% | -$54.1K | ﹤0.01% | 4883 |
|
|
2020
Q2 | $106K | Buy |
10,133
+6,517
| +180% | +$58.7K | ﹤0.01% | 4544 |
|
|
2020
Q1 | $26K | Sell |
3,616
-71
| -2% | -$737 | ﹤0.01% | 4893 |
|
|
2019
Q4 | $49K | Hold |
3,687
| – | – | ﹤0.01% | 5133 |
|
|
2019
Q3 | $57K | Buy |
3,687
+598
| +19% | +$7.77K | ﹤0.01% | 5125 |
|
|
2019
Q2 | $40K | Buy |
3,089
+496
| +19% | +$6.77K | ﹤0.01% | 5267 |
|
|
2019
Q1 | $46K | Sell |
2,593
-121
| -4% | -$1.9K | ﹤0.01% | 5171 |
|
|
2018
Q4 | $31K | Buy |
2,714
+253
| +10% | +$3.06K | ﹤0.01% | 5228 |
|
|
2018
Q3 | $35K | Buy |
2,461
+303
| +14% | +$4.3K | ﹤0.01% | 5305 |
|
|
2018
Q2 | $33K | Buy |
2,158
+322
| +18% | +$5.45K | ﹤0.01% | 5209 |
|
|
2018
Q1 | $25K | Sell |
1,836
-130
| -7% | -$2.47K | ﹤0.01% | 5022 |
|
|
2017
Q4 | $46K | Buy |
+1,966
| New | +$46.4K | ﹤0.01% | 4924 |
|
|
2017
Q3 | – | Sell |
-160
| Closed | -$6K | – | 5129 |
|
|
2017
Q2 | $6K | Buy |
+160
| New | +$4.4K | ﹤0.01% | 4739 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
JP Morgan Chase's PLSE Position: Q1 2026 in Review
JP Morgan Chase increased its Pulse Biosciences (PLSE) stake by 15% in Q1 2026, buying an estimated $20.2K and bringing the position to 8,199 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #5584.
JP Morgan Chase first reported a position in PLSE in Q2 2017 and has held it in 35 quarters since. The position peaked at $760K in Q4 2020. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- JP Morgan Chase held 8,199 shares of Pulse Biosciences worth $161K as of Q1 2026.
- JP Morgan Chase bought 1,094 Pulse Biosciences shares in Q1 2026, an estimated $20.2K.
- Pulse Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5584 holding.
- JP Morgan Chase first reported a position in Pulse Biosciences in Q2 2017 and has held it in 35 quarters since.
- JP Morgan Chase's Pulse Biosciences position peaked at $760K in Q4 2020.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.